Eflapegrastim
Generic name: Eflapegrastim
Brand names: Rolvedon
Dosage form: subcutaneous solution (xnst 13.2 mg/0.6 mL)
Drug class:
Colony stimulating factors
Usage of Eflapegrastim
Eflapegrastim is used in adults to treat Neutropenia, a lack of certain white blood cells caused by cancer, chemotherapy, or by other conditions.
Eflapegrastim is used in adults to treat neutropenia, a lack of certain white blood cells caused by cancer, bone marrow transplant, receiving chemotherapy, or by other conditions.
Eflapegrastim may also be used for purposes not listed in this medication guide.
Eflapegrastim side effects
Get emergency medical help if you have signs of an allergic Reaction: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Eflapegrastim can cause your spleen to become enlarged and it could rupture (tear). Call your doctor right away if you have sudden or severe pain in your left upper stomach spreading up to your shoulder.
Capillary leak syndrome is a rare but serious side effect. Call your doctor right away if you have signs of this condition: stuffy or runny nose followed by tiredness, thirst, decreased urination, trouble breathing, and sudden swelling or weight gain.
Eflapegrastim may cause serious side effects. Call your doctor at once if you have:
Common side effects of eflapegrastim may include:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Eflapegrastim
You should not use eflapegrastim if you are allergic to eflapegrastim, Filgrastim, or pegeflapegrastim.
Tell your doctor if you have ever had:
Tell your doctor if you are pregnant or breastfeeding.
Relate drugs
- Eflapegrastim
- Eflapegrastim-xnst
- Filgrastim
- Filgrastim-aafi
- Filgrastim-ayow
- Filgrastim-sndz
- Fulphila
- Fulphila (Pegfilgrastim Subcutaneous)
- Fulphila (Pegfilgrastim-jmdb Subcutaneous)
- Fylnetra
- Fylnetra (Pegfilgrastim Subcutaneous)
- Fylnetra (Pegfilgrastim-pbbk Subcutaneous)
- Granix
- Leukine
- Neulasta
- Neulasta Onpro Kit
- Neupogen
- Nivestym
- Nyvepria
- Nyvepria (Pegfilgrastim Subcutaneous)
- Nyvepria (Pegfilgrastim-apgf Subcutaneous)
- Pegfilgrastim
- Pegfilgrastim-apgf
- Pegfilgrastim-bmez
- Pegfilgrastim-cbqv
- Pegfilgrastim-fpgk
- Pegfilgrastim-jmdb
- Pegfilgrastim-pbbk
- Releuko
- Rolvedon
- Sargramostim
- Stimufend
- Stimufend (Pegfilgrastim Subcutaneous)
- Stimufend (Pegfilgrastim-fpgk Subcutaneous)
- Udenyca
- Udenyca (Pegfilgrastim Subcutaneous)
- Udenyca (Pegfilgrastim-cbqv Subcutaneous)
- Zarxio
- Ziextenzo
- ZIEXTENZO (Pegfilgrastim Subcutaneous)
- ZIEXTENZO (Pegfilgrastim-bmez Subcutaneous)
How to use Eflapegrastim
Usual Adult Dose for Neutropenia Associated with Chemotherapy:
Usual dose: 13.2 mg suBCUTAneously once per chemotherapy cycle Comments:-Dose should be given at least 24 hours after cytotoxic chemotherapy.-This drug should not be administered within the period from 14 days before to 24 hours after administration of cytotoxic chemotherapy.-This drug is not indicated for the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation.Use: To decrease the incidence of infection, manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of neutropenia and fever.
Warnings
Eflapegrastim can cause your spleen to become enlarged and it could rupture (tear). Call your doctor right away if you have sudden or severe pain in your left upper stomach spreading up to your shoulder.
What other drugs will affect Eflapegrastim
Other drugs may affect eflapegrastim, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all other medicines you use.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions